DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

2026 年 02 月 25 日 12:00 下午 - 2026 年 05 月 12 日 1:00 下午

DIA LIFT Series Biotech Masterclass: Empowering Biotech Breakthroughs

Building Fundable Ventures and Strategic Partnerships

Part 6: Modernizing Clinical Trials: How New Approaches and CRO Partnerships Accelerate Safe, Effective Drug Development

Session Chair(s)

Cynthia L. Verst, PHARMD, MS

Cynthia L. Verst, PHARMD, MS

President, R&D Solutions D&DI; 2023 President

IQVIA, United States

Robert  Goodwin, MBA, MSC

Robert Goodwin, MBA, MSC

Chief Operating Officer

Parexel, United States

Jay  Roberts, MBA

Jay Roberts, MBA

Partner

Ventac Partners, United States

One of the most time consuming and costly part of developing new drugs is the conduct of clinical trials. The goals of clinical trials are to test the safety and efficacy of new drugs in human populations. Clinical trials have to follow strict guidelines approved by the regulatory agencies. It is also important to choose the right group of patients from around the world, recruit them in an efficient manner and complete the trials on time and help with preparing the documents necessary for review and approval. There are a large number clinical research organizations (CRO’s) around the world that help with all aspects of clinical trials. The way clinical trials are conducted is constantly evolving. Efficient clinical trials can accelerate timelines for drug development and reduce the overall cost of bringing drugs to the market. The panelists will discuss how the clinical trials process is changing and helping bring safe and effective drugs to the public in short amount of time.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。